Universe Pharmaceuticals INC
UPC
$4.20
$0.4010.53%
NASDAQ
| 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -18.55M | -12.36M | -6.16M | -8.67M | -11.18M |
| Total Depreciation and Amortization | 499.80K | 504.30K | 508.80K | 504.20K | 499.60K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 10.92M | 5.54M | 152.60K | 735.30K | 1.32M |
| Change in Net Operating Assets | 1.02M | 3.82M | 6.62M | 6.68M | 6.73M |
| Cash from Operations | -6.11M | -2.49M | 1.12M | -755.80K | -2.63M |
| Capital Expenditure | -111.20K | -77.70K | -44.20K | -41.40K | -38.60K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 0.00 | 0.00 |
| Cash Acquisitions | -- | -- | -- | -1.91M | -3.82M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 0.00 | -- | -- | -- |
| Cash from Investing | -111.20K | -77.70K | -44.20K | -1.95M | -3.85M |
| Total Debt Issued | 9.62M | 7.65M | 5.67M | 7.62M | 9.56M |
| Total Debt Repaid | -7.03M | -7.04M | -7.06M | -5.60M | -4.14M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2.60M | 602.80K | -1.39M | 2.01M | 5.42M |
| Foreign Exchange rate Adjustments | -469.80K | -290.70K | -111.60K | -163.40K | -215.20K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4.09M | -2.26M | -426.20K | -854.00K | -1.28M |